UFLEX's Q1 profit was driven mainly by operations, not other income
Operating profit reached Rs 888.65 cr, while interest and depreciation together reduced profit before tax to Rs 491.37 cr.
Filed 14 Aug 2026, 19:54 IST · after market close · UFLEX (UFLEX)
Key takeaways
- UFlex reported consolidated Q1FY27 net profit of Rs 423.08 cr and EPS of Rs 58.62.
- Operating execution supported a 16.56% margin as management cited better volumes, capacity utilisation and efficiencies across key markets.
- Sales volumes rose +4.00% QoQ and +1.70% YoY to 173,471 MT, led by packaging films growth of +6.40% QoQ and +4.90% YoY.
Volume growth carried the quarter
UFlex's consolidated Q1FY27 revenue was Rs 5,366.03 cr and operating profit was Rs 888.65 cr, resulting in a 16.56% operating margin. Management attributed the core packaging performance to improved volumes, higher capacity utilisation and better operating efficiencies across key markets. Sales volumes reached 173,471 MT, with packaging films leading the increase.
Reported profit was not mainly other-income driven
Profit before tax was Rs 491.37 cr, while other income contributed Rs 32.00 cr, so non-operating income did not dominate reported pretax profit. The tax rate was 13.90%, and net profit was Rs 423.08 cr after interest of Rs 216.27 cr and depreciation of Rs 213.01 cr. There is no sequential or year-on-year cost bridge in the reported comparison data, so the margin movement cannot be quantified against an earlier period.
Expansion remains central to management's outlook
UFlex incurred Rs 4,782 million of Q1 capex across its Egypt, Mexico, Noida and Dharwad projects. The presentation said the 12-billion-pack Egypt aseptic facility is scheduled for commissioning in H1 FY27E, while the 54,000 MTPA Dharwad BOPP line is scheduled for FY27-28E; it also said the 39,600 MTPA Noida recycling project was commissioned on April 30, 2026. Management said Q2 should see some normalization from Q1's exceptionally strong realization, while its underlying growth trajectory and earnings quality remain priorities.
No market reaction to assess yet
The results were filed after market close, so there is no market reaction to assess in this note. The presentation also flagged continued pressure from low-priced imports in Europe, while saying localized sourcing is being used to reduce the risk from unscheduled supply-chain disruptions.
Q1FY27 at a glance
Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q1FY27 |
|---|---|
| Revenue | ₹5,366 cr |
| Other income | ₹32 cr |
| Expenses | ₹4,477 cr |
| Operating profit | ₹889 cr |
| Operating margin (%) | 16.56% |
| Interest | ₹216 cr |
| Depreciation | ₹213 cr |
| Profit before tax | ₹491 cr |
| Tax | ₹68 cr |
| Net profit | ₹423 cr |
| EPS (₹) | ₹58.62 |
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
This quarter
- Core packaging performance was supported by improved volumes, higher capacity utilization and enhanced operating efficiencies.
- Q1 sales volumes grew 4.0% QoQ and 1.7% YoY to 173,471 MT, led by Packaging Films growth.
Guidance & outlook
- UFlex expects to deliver sustainable and profitable growth in FY27 and beyond.
- Q2 is expected to normalize from Q1's exceptionally strong realization, while the underlying growth trajectory remains intact.
- UFlex expects robust FY27 growth and continued improvement in earnings quality.
Expansion
- UFlex incurred Rs.4,782 million of Q1 capex across the Egypt, Mexico, Noida and Dharwad projects.
- The 12-billion-pack Egypt greenfield aseptic project is scheduled for commissioning in H1 FY27E.
- The 54,000 MTPA Dharwad brownfield BOPP line is scheduled for FY27-28E.
- The 39,600 MTPA Noida Sector 155 recycling project was commissioned on April 30, 2026.
New initiatives
- UFlex is using localized sourcing to de-risk unscheduled supply-chain disruptions.
- UFlex is shifting toward value-added packaging films as a key growth theme.
Problems & risks
- Europe faced continued pressure from low-priced imports.
What to watch
- Whether sales volumes build on 173,471 MT after the stated Q2 normalization.
- Whether operating margin holds around 16.56% as capacity utilisation and efficiencies develop.
- Progress toward the stated H1 FY27E commissioning of the 12-billion-pack Egypt aseptic facility.